References
- Anderson WF. Human gene therapy. Nature 1998; 392: 25–30
- Benns JM, Kim SW. Tailoring new gene delivery designs for specific targets. J Drug Target 2000; 8: 1–12
- Conry RM, White SA, Fultz PN, Khazaeli MB, Strong TV, Allen KO, Barlow DL, Moore SE, Coan PN, Davis I, Curiel DT, Lo Buglio AF. Polynucleotide immunization of nonhuman primates against carcinoembryonic antigen. Clin Cancer Res 1998; 4: 2903–2912
- Davis SS. Biomedical applications of nanotechnology-implications for drug targeting and gene therapy. Trends Biotechnol 1997; 15: 217–224
- El-Aneed A. An overview of current delivery systems in cancer gene therapy. J Control Rel 2004; 94: 1–14
- Hanke P, Serwe M, Dombrowski F, Sauerbruch T, Caselmann WH. DNA vaccination with AFP-encoding plasmid DNA prevents growth of subcutaneous AFP-expressing tumors and does not interfere with liver regeneration in mice. Cancer Gene Ther 2002; 9: 346–355
- Itaka K, Yamauchi K, Harada A, Nakamura K, Kawaguchi H, Kataoka K. Polyion complex micelles from plasmid DNA and poly(ethylene glycol)-poly(l-lysine) block copolymer as serum-tolerable polyplex system: Physicochemical properties of micelles relevant to gene transfection efficiency. Biomaterials 2003; 24: 4495–4506
- Kawabata K, Takakura Y, Hashida M. The fate of plasmid DNA after intravenous injection in mice: Involvement of scavenger receptors in its hepatic uptake. Pharm Res 1995; 12: 825–830
- Licciardi M, Campisi M, Cavallaro G, Cervello M, Azzolina A, Giammona G. Synthesis and characterization of polyaminoacidic polycations for gene delivery. Biomaterials 2006; 27: 2066–2075
- Mehnert W, Mader K. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev 2001; 47: 165–196
- Nabel GJ. Development of optimized vectors for gene therapy. Proc Natl Acad Sci USA 1999; 96: 324–326
- Olbrich C, Bakowsky U, Lehr CM, Muller RH, Kneuer C. Cationic solid lipid nanoparticles can efficiently bind and transfect plasmid DNA. J Control Rel 2001; 77: 345–355
- Pedersen N, Hansen S, Heydenreich AV, Kristensen HG, Poulsen HS. Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands. Eur J Pharm Biopharm 2006; 62: 155–162
- Peng KW, Vile R. Vector development for cancer gene therapy. Tumor Target 1999; 4: 3–11
- Schwarz C, Mehnert W. Sterilization of drug-free and tetracaine-loaded solid lipid nanoparticles (SLN). 1995; 485–486, Proceeding of the First World Meeting APGI/APV, Budapest
- Schwarz C, Mehnert W. Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN). Int J Pharm 1997; 157: 171–179
- Shi F, Rakhmilevich AL, Heise CP, Oshikawa K, Sondel PM, Yang NS, Mahvi MD. Intratumoral injection of interleukin-12 plasmid DNA, either naked or in complex with cationic lipid, results in similar tumor regression in a murine model. Mol Cancer Ther 2002; 1: 949–957
- Tabatt K, Sameti M, Olbrich C, Muller RH, Lehr CM. Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticles-mediated gene transfer. Eur J Pharm Biopharm 2004; 57: 155–162
- Walther W, Stein U, Fichtner I, Voss C, Schmidt T, Schleef M, Nellessen T, Schlag PM. Intratumoral low-volume jet-injection for efficient nonviral gene transfer. Mol Biotechnol 2002; 21: 105–115
- Weijun L, François N, Jr, Francis SC. GALA: A designed synthetic pHresponsive amphipathic peptide with applications in drug and gene delivery. Adv Drug Del Rev 2004; 56: 967–985
- Wissing SA, Kayser O, Muller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Del Rev 2004; 56: 1257–1272
- Yang SC, Lu LF, Cai Y, Zhu JB, Liang BW, Yang CZ. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Control Rel 1999; 59: 299–307